Antidiabetics Market Is Predicted To Grow Quickly Due To Growing Worldwide Prevalence Of Diabetes Till 2020: Grand View Research, Inc.
Global Antidiabetics Market is expected to reach USD
84.13 billion by 2020, according to a new study by Grand View Research, Inc.
Growing prevalence of diabetes is the primary driver of this market. Growth in
prevalence of disease causing lifestyle disorders such as irregular dietary
habits and obesity is also expected to boost product demand by triggering
incidence rates of target diseases. Future commercialization of products
currently in the pipeline and the presence of large untapped opportunities in
the emerging Asia Pacific and Latin American markets is expected to fuel future
market growth.
Insulin was the most revenue
generating segment and its market was valued at over USD 20.0 billion in 2013.
Insulin is also one of the most lucrative segments of this market. Introduction
of new products exhibiting higher efficacy coupled with the presence of
favorable government initiatives are some factors attributing to its market
attractiveness.
Browse full research report on Antidiabetics Market: http://www.grandviewresearch.com/industry-analysis/antidiabetics-market
Further key findings from
the study suggest:
- Long acting insulin was the leading product segment
in 2013 and is expected to grow at the CAGR of over 15.0% during the
forecast period. The introduction of advanced products, high prices
associated with these products and the phasing out of human insulin are
some key factors attributing for its large share.
- Rapid uptake of newly approved DPP-4 inhibitors such
as Januvia, Nesina and Onglyza on account of their once daily dosage
regimens and safety profiles catalyzed the growth of this market.
- North America was the most matured antidiabetics
market in 2013 accounting for over 43.0% of the market High market
penetration of insulin and other antidiabetics and the presence of
sophisticated reimbursement framework are expected to drive regional
market growth.
- Asia Pacific is expected to present manufacturers
with lucrative future growth opportunities. Large presence of unmet
patient needs and rapidly improving healthcare infrastructure are some
factors expected to drive market growth in the region. The market is also
expected to be driven by the introduction of cheaper products made
available by local manufacturers.
- Some key market players of antidiabetics include Sanofi
Aventis, Takeda Pharmaceuticals, Eli Lilly, Oramed Pharmaceuticals Inc.,
Merck & Co. Inc., Novo Nordisk, Bristol-Myers Squibb, Halozyme
Therapeutics and Pfizer.
- The market is oligopolistic in nature with few
players accounting for over 70% of the market. Extensive R&D
investments aimed at new product development and entering new markets via
government contracts are the key sustainability strategies adopted by
these organizations.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/pharmaceuticals
For the purpose of this study, Grand View Research has
segmented the global antidiabetics market on the basis of product and region:
Global Insulin Product Outlook (Revenue, USD Million,
2012 - 2020)
• Rapid acting
• Long acting
• Premixed
• Premixed analog
• Short acting
• Intermediate acting
Global Antidiabetics Product Outlook (Revenue, USD Million, 2012 - 2020)
• Alpha-glucosidase inhibitors
• Biguanides
• Sulphonylureas
• GLP-1 agonist
• Meglitinides
• DPP-4 inhibitors
• SGLT – 2
• Thiazolodinediones
Antidiabetics Regional Outlook (Revenue, USD Million, 2012 - 2020)
• North America
• Europe
• Asia Pacific
• RoW
• Rapid acting
• Long acting
• Premixed
• Premixed analog
• Short acting
• Intermediate acting
Global Antidiabetics Product Outlook (Revenue, USD Million, 2012 - 2020)
• Alpha-glucosidase inhibitors
• Biguanides
• Sulphonylureas
• GLP-1 agonist
• Meglitinides
• DPP-4 inhibitors
• SGLT – 2
• Thiazolodinediones
Antidiabetics Regional Outlook (Revenue, USD Million, 2012 - 2020)
• North America
• Europe
• Asia Pacific
• RoW
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
Comments
Post a Comment